5980 HORTON STREET, EMERYVILLE, CA
Reports Pipeline Progress and Second Quarter 2026 Financial Results
Ex-99.1
News
Names Greg Martini as Chief Financial Officer
Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results
Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Investor Presentation
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
SEC Staff Correspondence
Correspondence
Submission Upload
Deregistration Letter